Literature DB >> 24273589

Intellectual Disability, Mild Cognitive Impairment, and Risk for Dementia.

Wayne P Silverman1, Warren B Zigman, Sharon J Krinsky-McHale, Robert Ryan, Nicole Schupf.   

Abstract

People with intellectual disability (ID) are living longer than ever before, raising concerns about old-age associated disorders. Dementia is among the most serious of these disorders, and theories relating cognitive reserve to risk predict that older adults with ID should be particularly vulnerable. Previous estimates of relative risk for dementia associated with ID have been inconsistent, and the present analyses examined the possible influence of variation in diagnostic criteria on findings. As expected, relaxation in the stringency of case definition for adults with ID increased relative risk, underscoring the importance of developing valid criteria for defining mild cognitive impairment, early dementia, and distinguishing between the two in adults with ID. Once available, these standards will contribute to more effective evidence-based planning.

Entities:  

Keywords:  dementia; incidence; intellectual disability; mild cognitive impairment; relative risk

Year:  2013        PMID: 24273589      PMCID: PMC3834861          DOI: 10.1111/jppi.12042

Source DB:  PubMed          Journal:  J Policy Pract Intellect Disabil        ISSN: 1741-1122


  30 in total

Review 1.  The magnitude of dementia occurrence in the world.

Authors:  Anders Wimo; Bengt Winblad; Hedda Aguero-Torres; Eva von Strauss
Journal:  Alzheimer Dis Assoc Disord       Date:  2003 Apr-Jun       Impact factor: 2.703

Review 2.  Mild cognitive impairment.

Authors:  Serge Gauthier; Barry Reisberg; Michael Zaudig; Ronald C Petersen; Karen Ritchie; Karl Broich; Sylvie Belleville; Henry Brodaty; David Bennett; Howard Chertkow; Jeffrey L Cummings; Mony de Leon; Howard Feldman; Mary Ganguli; Harald Hampel; Philip Scheltens; Mary C Tierney; Peter Whitehouse; Bengt Winblad
Journal:  Lancet       Date:  2006-04-15       Impact factor: 79.321

3.  Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education.

Authors:  Y Stern; H Andrews; J Pittman; M Sano; T Tatemichi; R Lantigua; R Mayeux
Journal:  Arch Neurol       Date:  1992-05

Review 4.  Alzheimer's disease in Down syndrome: neurobiology and risk.

Authors:  Warren B Zigman; Ira T Lott
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2007

5.  Neurological changes and emotional functioning in adults with Down Syndrome.

Authors:  L D Nelson; D Orme; K Osann; I T Lott
Journal:  J Intellect Disabil Res       Date:  2001-10

6.  The relationship of dementia prevalence in older adults with intellectual disability (ID) to age and severity of ID.

Authors:  A Strydom; A Hassiotis; M King; G Livingston
Journal:  Psychol Med       Date:  2008-04-15       Impact factor: 7.723

7.  Validity of criteria for dementia in older people with intellectual disability.

Authors:  Andre Strydom; Trevor Chan; Cormac Fenton; Rebekah Jamieson-Craig; Gill Livingston; Angela Hassiotis
Journal:  Am J Geriatr Psychiatry       Date:  2013-03       Impact factor: 4.105

8.  The prevalence of dementia, depression and neurosis in later life: the Liverpool MRC-ALPHA Study.

Authors:  P A Saunders; J R Copeland; M E Dewey; C Gilmore; B A Larkin; H Phaterpekar; A Scott
Journal:  Int J Epidemiol       Date:  1993-10       Impact factor: 7.196

Review 9.  Cognitive reserve.

Authors:  Yaakov Stern
Journal:  Neuropsychologia       Date:  2009-03-13       Impact factor: 3.139

Review 10.  Population-based neuropathological studies of dementia: design, methods and areas of investigation--a systematic review.

Authors:  Julia Zaccai; Paul Ince; Carol Brayne
Journal:  BMC Neurol       Date:  2006-01-09       Impact factor: 2.474

View more
  7 in total

1.  Rapid assessment of cognitive function in down syndrome across intellectual level and dementia status.

Authors:  D M Walsh; E Doran; W Silverman; A Tournay; N Movsesyan; I T Lott
Journal:  J Intellect Disabil Res       Date:  2015-05-29

2.  Joint-label fusion brain atlases for dementia research in Down syndrome.

Authors:  Nazek Queder; Michael J Phelan; Lisa Taylor; Nicholas Tustison; Eric Doran; Christy Hom; Dana Nguyen; Florence Lai; Margaret Pulsifer; Julie Price; William C Kreisl; Herminia D Rosas; Sharon Krinsky-McHale; Adam M Brickman; Michael A Yassa; Nicole Schupf; Wayne Silverman; Ira T Lott; Elizabeth Head; Mark Mapstone; David B Keator
Journal:  Alzheimers Dement (Amst)       Date:  2022-05-25

Review 3.  Cell models for Down syndrome-Alzheimer's disease research.

Authors:  Yixing Wu; Nicole R West; Anita Bhattacharyya; Frances K Wiseman
Journal:  Neuronal Signal       Date:  2022-04-08

Review 4.  Cognitive Rehabilitation of Dementia in Adults with Down Syndrome: A Review of Non-Pharmacological Interventions.

Authors:  Luciana Mascarenhas Fonseca; Anna Carolina Rufino Navatta; Cássio M C Bottino; Eliane Correa Miotto
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2015-09-18

5.  Down syndrome: Distribution of brain amyloid in mild cognitive impairment.

Authors:  David B Keator; Michael J Phelan; Lisa Taylor; Eric Doran; Sharon Krinsky-McHale; Julie Price; Erin E Ballard; William C Kreisl; Christy Hom; Dana Nguyen; Margaret Pulsifer; Florence Lai; Diana H Rosas; Adam M Brickman; Nicole Schupf; Michael A Yassa; Wayne Silverman; Ira T Lott
Journal:  Alzheimers Dement (Amst)       Date:  2020-04-17

6.  Bereavement and behavioral changes as risk factors for cognitive decline in adults with Down syndrome.

Authors:  Luciana Mascarenhas Fonseca; Melaine Cristina de Oliveira; Laura Maria de Figueiredo Ferreira Guilhoto; Esper Abrao Cavalheiro; Cássio Mc Bottino
Journal:  Neuropsychiatr Dis Treat       Date:  2014-11-17       Impact factor: 2.570

7.  The Association between Sex and Risk of Alzheimer's Disease in Adults with Down Syndrome.

Authors:  Pooja Girish Mhatre; Joseph H Lee; Deborah Pang; Warren B Zigman; Benjamin Tycko; Sharon J Krinsky-McHale; Yuchen Yang; Wayne Silverman; Nicole Schupf
Journal:  J Clin Med       Date:  2021-07-01       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.